Lakefront Biotherapeutics (LKFT) EBIT Margin Growth (1y) (2015 - 2026)
Lakefront Biotherapeutics (LKFT) EBIT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3,609.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1,536.00 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | -77,124.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,124.00 |
| Dec 31, 2025 | -10,608.00 |
| Sep 30, 2025 | -52,822.00 |
| Jun 30, 2025 | 64,439.00 |
| Mar 31, 2025 | -15,861.00 |
| Dec 31, 2024 | 15,017.00 |
| Sep 30, 2024 | -9,584.00 |
| Jun 30, 2024 | -38,116.00 |
| Mar 31, 2024 | -2,883.00 |
| Dec 31, 2023 | 4,233.00 |
| Sep 30, 2023 | 435.00 |
| Mar 31, 2023 | -873.00 |
| Dec 31, 2022 | 258.00 |
| Mar 31, 2022 | 2,909.00 |
| Dec 31, 2021 | 2,873.00 |
| Jun 30, 2021 | 5,509.00 |
| Mar 31, 2021 | -1.00 |
| Dec 31, 2020 | -3,094.00 |
| Sep 30, 2020 | -11,730.00 |
| Jun 30, 2020 | -1,300.00 |